A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles privately for source information, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source.
Some professionals stated the demand for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or prison.
Platform Response and Content Removal
Based on TikTok, the platform has removed problematic content and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Research also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at residence.
After moments of entering one community, a seller posted WhatsApp details, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, health issues or past usage.
Product Details and Costs
Within these communities, posts display black plastic packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they can’t verify. Although the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has previously encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to possibly significant health risks”.